Outcomes of Carlevale-type scleral-fixated intraocular lenses as a stable platform in silicone oil-filled eyes: a multicenter study

Abstract To evaluate functional, refractive, and morphological outcomes, and silicone oil (SiO)-related complications of Carlevale-type scleral-fixated intraocular lens (C-IOL) implantation with SiO tamponade. This multicenter case series included nine eyes that underwent C-IOL implantation combined with SiO tamponade, either simultaneously during primary retinal detachment surgery (56%), or sequentially, with the C-IOL already in place before retinal detachment repair and SiO tamponade (44%), across three centers. SiO tamponade consisted of standard 5000 cSt silicone oil (78%) or heavy fluorinated silicone oil (Densiron 68, 22%). Best-corrected visual acuity (BCVA), spherical equivalent (SE), intraocular pressure (IOP), SiO position, C-IOL stability, and adverse events were recorded preoperatively and at follow-up. Median age was 75.0 years (IQR 67.0–79.0); 67% were male. Median follow-up was 36.7 weeks (IQR 25.4–55.0). BCVA improved from 2.3 logMAR (IQR 1.3–2.3) preoperatively to 0.9 logMAR (IQR 0.9–1.8) at last follow-up (median ΔBCVA − 0.6) in 67% of eyes. Median SE remained near emmetropia, though with individual variability and available in only 6/9 eyes at ≥ 36 weeks. No IOP measurement exceeded 21 mmHg. Anatomical success was achieved in 78% of eyes. No clinically documented C-IOL decentration, tilt, or dislocation occurred. SiO was explanted in 33% of eyes at a median of 25.4 weeks (IQR 16.7–31.1); the remaining eyes retained tamponade through last follow-up. C-IOL opacification occurred in 22% (one explantation). Anterior SiO migration occurred in 44%, mostly limited to a small, clinically non-significant bubble; diffuse migration occurred in one eye only after explantation. Anterior-chamber irrigation was required in 22%. The combined surgical management of vitreoretinal surgery, SiO tamponade, and C-IOL fixation was associated with visual improvement, high anatomical success, and no clinically documented C-IOL decentration, tilt, or dislocation, although C-IOL opacification and anterior SiO migration warrant further prospective, comparative evaluation.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-16
DOI
https://doi.org/10.1038/s41598-026-78391-8
Primary Topic
Retinal and Macular Surgery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Outcomes of Carlevale-type scleral-fixated intraocular lenses as a stable platform in silicone oil-filled eyes: a multicenter study

Lasse Wolfram, Jan-Philipp Bodenbender, Kai Januschowski, El Mahdi Wahib et al.
1 links
Scientific Reports
Retinal and Macular Surgery
article

Outcomes of Carlevale-type scleral-fixated intraocular lenses as a stable platform in silicone oil-filled eyes: a multicenter study

Lasse Wolfram, Jan-Philipp Bodenbender, Kai Januschowski, El Mahdi Wahib, Spyridon Dimopoulos, Emil Nasyrov, Berenike Kunzmann
article en

Abstract

Abstract To evaluate functional, refractive, and morphological outcomes, and silicone oil (SiO)-related complications of Carlevale-type scleral-fixated intraocular lens (C-IOL) implantation with SiO tamponade. This multicenter case series included nine eyes that underwent C-IOL implantation combined with SiO tamponade, either simultaneously during primary retinal detachment surgery (56%), or sequentially, with the C-IOL already in place before retinal detachment repair and SiO tamponade (44%), across three centers. SiO tamponade consisted of standard 5000 cSt silicone oil (78%) or heavy fluorinated silicone oil (Densiron 68, 22%). Best-corrected visual acuity (BCVA), spherical equivalent (SE), intraocular pressure (IOP), SiO position, C-IOL stability, and adverse events were recorded preoperatively and at follow-up. Median age was 75.0 years (IQR 67.0–79.0); 67% were male. Median follow-up was 36.7 weeks (IQR 25.4–55.0). BCVA improved from 2.3 logMAR (IQR 1.3–2.3) preoperatively to 0.9 logMAR (IQR 0.9–1.8) at last follow-up (median ΔBCVA − 0.6) in 67% of eyes. Median SE remained near emmetropia, though with individual variability and available in only 6/9 eyes at ≥ 36 weeks. No IOP measurement exceeded 21 mmHg. Anatomical success was achieved in 78% of eyes. No clinically documented C-IOL decentration, tilt, or dislocation occurred. SiO was explanted in 33% of eyes at a median of 25.4 weeks (IQR 16.7–31.1); the remaining eyes retained tamponade through last follow-up. C-IOL opacification occurred in 22% (one explantation). Anterior SiO migration occurred in 44%, mostly limited to a small, clinically non-significant bubble; diffuse migration occurred in one eye only after explantation. Anterior-chamber irrigation was required in 22%. The combined surgical management of vitreoretinal surgery, SiO tamponade, and C-IOL fixation was associated with visual improvement, high anatomical success, and no clinically documented C-IOL decentration, tilt, or dislocation, although C-IOL opacification and anterior SiO migration warrant further prospective, comparative evaluation.

Scientific ReportsVol. 16(1)
Krankenhaus der Barmherzigen Brüder Trier (DE), University of Tübingen (DE)
Universitätsklinikum Tübingen
Good health and well-being
Retinal and Macular Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon